Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone.

about

Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone.

Item

http://www.wikidata.org/entity/Q47449416

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Serum Pre-Albumin Predicts the ...... ents Treated With Abiraterone.

@en

Serum Pre-Albumin Predicts the ...... ents Treated With Abiraterone.

@nl

type

Item

label

Serum Pre-Albumin Predicts the ...... ents Treated With Abiraterone.

@en

Serum Pre-Albumin Predicts the ...... ents Treated With Abiraterone.

@nl

prefLabel

Serum Pre-Albumin Predicts the ...... ents Treated With Abiraterone.

@en

Serum Pre-Albumin Predicts the ...... ents Treated With Abiraterone.

@nl

P1476

Serum Pre-Albumin Predicts the ...... ents Treated With Abiraterone.

@en

P2093

Baijun Dong

http://www.w3.org/2001/XMLSchema#string

Chenfei Chi

http://www.w3.org/2001/XMLSchema#string

Fan Xu

http://www.w3.org/2001/XMLSchema#string

Hongyang Qian

http://www.w3.org/2001/XMLSchema#string

Jiahua Pan

http://www.w3.org/2001/XMLSchema#string

Jianian Hu

http://www.w3.org/2001/XMLSchema#string

Liancheng Fan

http://www.w3.org/2001/XMLSchema#string

Lixin Zhou

http://www.w3.org/2001/XMLSchema#string

Rui Wang

http://www.w3.org/2001/XMLSchema#string

Sanwei Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Abiraterone in metastatic prostate cancer without previous chemotherapy

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Cancer statistics, 2016

Alpha emitter radium-223 and survival in metastatic prostate cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

P304

3448-3455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.21134

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29151928

http://www.w3.org/2001/XMLSchema#string

P932

5687158

http://www.w3.org/2001/XMLSchema#string